Becker's Healthcare October 15, 2024
Naomi Diaz

The Drug Enforcement Administration is signaling that it will extend flexibilities, enacted during the COVID-19 pandemic, that allows healthcare providers to prescribe specific controlled substances via telehealth, Politico reported Oct. 11.

Seven things to know:

  1. A new rule called “Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” was sent to the White House for review on Oct. 10.
  2. According to Politico, it’s not yet known how long the extension will last.
  3. The possible delay means that either Vice President Kamala Harris or former President Donald Trump’s administration will have to address the issue.
  4. This extension would allow healthcare providers to prescribe specific controlled substances via telehealth. This includes stimulant medications for attention-deficit/hyperactivity disorder,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Digital Health, Govt Agencies, Patient / Consumer, Provider, Technology, Telehealth
Related Articles:
Lawmakers calls for extending telemedicine flexibilities, object to proposed DEA rule
DEA to Extend Telehealth Flexibilities for Controlled Substances a Third Time
Telehealth Is ‘Where the Puck Is Going’ in Youth Behavioral Health
Investing in Virtual Care to Expand Health System Capacity and Retain Patients
STAT+: Frustrated telehealth providers say their businesses face ‘doom and gloom’

Share This Article